home / stock / emma / emma quote
Last: | $ |
---|---|
Change Percent: | -6.91% |
Open: | $1.90 |
Close: | $1.75 |
High: | $1.935 |
Low: | $1.51 |
Volume: | 43,926 |
Last Trade Date Time: | 02/12/2020 04:43:02 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $1.90 | $1.75 | $1.935 | $1.51 | 43,926 | 02-12-2020 |
$ | $1.735 | $1.88 | $1.89 | $1.69 | 32,929 | 02-11-2020 |
$ | $1.65 | $1.73 | $1.73 | $1.50 | 16,810 | 02-10-2020 |
$ | $1.27 | $1.64 | $1.65 | $1.27 | 19,429 | 02-07-2020 |
$ | $1.12 | $1.27 | $1.27 | $1.04 | 21,081 | 02-06-2020 |
$ | $1.00 | $1.13 | $1.13 | $0.95 | 21,666 | 02-05-2020 |
$ | $1.13 | $1.10 | $1.155 | $1.00 | 22,050 | 02-04-2020 |
$ | $1.16 | $1.13 | $1.16 | $1.12 | 641 | 02-03-2020 |
$ | $1.26 | $1.22 | $1.27 | $1.16 | 16,010 | 01-31-2020 |
$ | $1.36 | $1.25 | $1.41 | $1.20 | 7,077 | 01-30-2020 |
$ | $1.25 | $1.36 | $1.42 | $1.23 | 34,101 | 01-29-2020 |
$ | $1.25 | $1.20 | $1.295 | $1.00 | 35,150 | 01-28-2020 |
$ | $1.52 | $1.38 | $1.52 | $1.35 | 41,900 | 01-27-2020 |
$ | $1.57 | $1.55 | $1.60 | $1.55 | 3,390 | 01-24-2020 |
$ | $1.573 | $1.68 | $1.75 | $1.56 | 21,048 | 01-23-2020 |
$ | $1.685 | $1.63 | $1.69 | $1.63 | 10,648 | 01-22-2020 |
$ | $1.75 | $1.70 | $1.92 | $1.62 | 40,081 | 01-21-2020 |
$ | $1.95 | $1.86 | $1.95 | $1.855 | 10,258 | 01-20-2020 |
$ | $1.95 | $1.86 | $1.95 | $1.855 | 10,258 | 01-17-2020 |
$ | $1.89 | $1.94 | $1.95 | $1.75 | 11,203 | 01-16-2020 |
News, Short Squeeze, Breakout and More Instantly...
Emmaus Life Sciences Incorporation Company Name:
EMMA Stock Symbol:
NYSE Market:
Emmaus Life Sciences Incorporation Website:
Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program PR Newswire TORRANCE, Calif. , July 12, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCPK: EMMA) , a commercial-stage biopharmaceuti...
Emmaus Life Sciences Reports 2023 Financial Results PR Newswire TORRANCE, Calif. , July 3, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCPK: EMMA) , a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today r...
ADDvantage Technologies Group Inc. (AEYGQ) is expected to report for Q1 2024 ContraFect Corporation (CFRXQ) is expected to report for Q1 2024 American Clean Resources Group Inc (ACRG) is expected to report for Q1 2024 Atlantic Lithium Ltd Ord Fully Paid (ALLIF) is expected to report f...